The impact of diagnosis subject to reimbursement on life expectancy, the ability to work, and the quality of life: The experts’ assessment

Abstract

The ex-post retrospective analysis of the health care reform in Latvia has been performed by several authors; therefore in writing this paper, the author also considered it essential to try and predict its future prospects, specifically, to carry out an ex-ante analysis of reimbursement arrangements for medicines and medical devices in outpatient treatment (“reimbursement arrangements”). An ex-antepolicy impact analysis takes place at the beginning of the policy development process when policy planners and experts try to project, by means of various quantitative and qualitative methods, the various kinds of consequences that the society will face as a result of implementation of the policy. Taking into account the circumstances of limited state budget resources for the medicines reimbursement arrangements in Latvia, the aim of this research is to evaluate by the experts’ method the impact of the reimbursed diseases on the life expectancy, the ability to work, and the quality of life, to identify the priorities. According to the experts’ judgments the group of diagnoses “Neoplasms” gives the greatest common impact on the life expectancy, the ability to work, and quality of life, followed by the “Diseases of the circulatory system” and “Diseases of the blood and blood forming organs and certain disorders involving the immune mechanisms”.